Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
33.96
+0.77 (2.32%)
At close: Mar 16, 2026, 4:00 PM EDT
33.96
0.00 (0.00%)
After-hours: Mar 16, 2026, 4:55 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $2.01 billion as of March 16, 2026. Its market cap has increased by 374.65% in one year.
Market Cap
2.01B
Enterprise Value
1.68B
1-Year Change
374.65%
Ranking
Category
Stock Price
$33.96
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $2.01B, an increase of 149.70%. That is a compound annual growth rate of 14.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.90B | 4.57% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 1.98B |
| Veradermics | 1.97B |
| Celldex Therapeutics | 1.96B |
| Tyra Biosciences | 1.95B |
| Ocular Therapeutix | 1.91B |
| Mesoblast | 1.87B |
| AnaptysBio | 1.86B |
| Aurinia Pharmaceuticals | 1.85B |